Medicaid Launches Innovative Payment Model to Expand Access to Sickle Cell Gene Therapies – Patient Worthy

Medicaid Launches Innovative Payment Model to Expand Access to Sickle Cell Gene Therapies – Patient Worthy

The U.S. Medicaid program has taken a pioneering step to ensure that new gene therapies for sickle cell disease (SCD) are accessible to the millions of Americans who rely on public health insurance, as was reported by BioPharma Dive. On July 25, 2024, the Centers for Medicare & Medicaid Services (CMS) announced the launch of […]